← Evidence library

BIB_057

Eggermont AMM, Blank CU, Mandala M, et al. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. NEJM 2018;378:1789–1801. KEYNOTE-054. [Tasks: L, 18] Tier: 2 Grade: A Retrieved: 2026-05-06

Evidence grade

A

Tier

2

Cited by tasks

L, 18

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_057/findings.md (research corpus). This page is a short context summary — not individualised medical advice.